Abstract: Iridium complexes containing hexadentate ligands are disclosed. Multidentate iridium complexes of Formula II showed desired properties in term of EQE, LT, CIE, etc.

Abstract: Provided are organometallic complexes including 5-membered heterocyclic rings. The compounds include a ligand LA having a structure of Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: Provided are organometallic compounds comprising a first ligand LA of Formula I Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound including a first ligand LA selected from the following group: is disclosed.

Abstract: A compound of Formula (LA)n-M-(LC)m, wherein the ligand LA is of Formula I, and the ligand LC is selected from Formula I that is different than ligand LA, a monoanionic bidentate ligand, or a monoanionic monodentate ligand. M is a metal; and n is 1 or 2, and m is 0, 1 or 2. Ring A is a 5-membered or 6-membered heteroaryl ring, which is bonded to Ring B; Z is selected from O or S; Z1 is selected from a carbene C or N; and Z2 is selected from C or N. Moreover, two adjacent ring carbons of Ring B will form a group of formula D, wherein * represents the point of attachment to the two adjacent ring carbons, Formula D, wherein X is selected from NRN, O, S, or Se; and RN is selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, heteroalkyl, aryl, heteroaryl, and combinations thereof; and Y1, Y2, Y3, and Y4 are independently CRY1, CRY2, CRY3, and CRY4, respectively, or N, and Ring D has no more than two nitrogen ring atoms.

Abstract: Ligands with fused spirocyclic substitutions and metal complexes formed with such ligands and having improved performance in OLED applications are disclosed.

Abstract: A compound having the formula Ir(LA)(LB), where LA has a structure of Formula I and LB is a bidentate ligand is disclosed. In the structure of Formula I, rings A, B, C, and D are each independently 5- or 6-membered carbocyclic or heterocyclic rings; each of Z1 to Z8 is C or N; LA has at least one Ir—C bond; L is CR or N; each R1 R2, R3, and R4 is independently hydrogen or one of the preferred general substituents; and any two substituents may be joined or fused together to form a ring. Organic light emitting devices, consumer products, and formulations containing the compounds are also disclosed.

Abstract: Provided are organometallic compounds of Formula I Also provided are formulations including these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound having a first ligand LA having the Formula: Formula I is disclosed, wherein rings A is a 5- or 6-membered carbocyclic or heterocyclic ring; wherein RA and RB each independently represent mono to the possible maximum number of substitution, or no substitution; wherein Z1 is carbon or nitrogen; wherein each RA and RB is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two substituents are optionally joined or fused into a ring; wherein X1 to X4 each independently represent a carbon or nitrogen; wherein at least one of X1 to X4 is nitrogen; wherein the ligand LA is coordinated to a metal M; wherein the metal M can be coordinated to other ligands; and wherein the ligand LA is optionally l

Abstract: A compound including a first ligand LX of Formula II is disclosed, where F is a 5-membered or 6-membered carbocyclic or heterocyclic ring; each RF and RG independently represents mono to the maximum possible number of substitutions, or no substitution; Z3 and Z4 are each independently C or N and coordinated to a metal M to form a 5-membered chelate ring; G is a fused ring structure comprising five or more fused heterocyclic or carbocyclic rings, of which one or two rings are of Formula III the fused heterocyclic or carbocyclic rings in the fused ring structure G are 5-membered or 6-membered; of which if two or more 5-membered rings are present, at least two of the 5-membered rings are fused to one another; Y can be one of BR?, NR?, PR?, O, S, Se, C?O, S?O, SO2, CR?R?, SiR?R?, and GeR?R?; the metal M can be coordinated to other ligands; and the ligand LX can be linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand.

Abstract: An organometallic complex including a ligand LA having a structure represented by one of the following formula and coordinated to Ir is disclosed.

Abstract: Provided are organometallic compounds of formula Os(LA)x(LB)y(LC)z, where LA has a structure of Formula I with the two indicated dashed lines for coordination to Os: Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound having a structure of Formula I, is provided. In Formula I, X1-X7, Z1 and Z2 are each independently C or N; Z3 is selected from BR?, NR?, PR?, O, S, Se, C?O, S?O, SO2, CR?R?, SiR?R?, and GeRR?; L is selected from O, S, and NR; C1, C2, and C3 are all carbon atoms; the bonds represent single bond or double bond to fulfill the valency requirement of a neutral compound; each R1, R2, R3, R, R?, R?, RA, and RB is independently hydrogen or a substituent; and any two of R1, R2, R3, R, R?, R?, RA, and RB can be joined or fused together to form a ring. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: Provided are organometallic compounds including a ligand LA of Formula I Also provided are formulations including these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds having a structure of Formula I: Also provided are formulations including these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are compounds including a ligand LA of the following Formula I: that contain heavy elements like Sb, Bi, or Te. Also provided are formulations including such compounds. Further provided are OLEDs and related consumer products that utilize such compounds.

Abstract: A composition of matter that includes a novel combination of host compounds containing indol-fused hosts and emissive dopants containing benzofuran or azabenzofuran ligand is disclosed,

Abstract: Provided are organometallic compounds including a ligand LA having a structure of Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound comprising a ligand LA comprising a moiety L having a structure of Formula I is provided. In Formula I, LA coordinated to a metal M; A1 is selected from B, N, P, P?O, P?S, Al, Ga, SiR?, GeR?, and SnR?; where rings A, B, and C are 5- or 6-membered rings; Y1, Y2, and Y3 are selected from direct bonds, the metal M, and a variety of linkers; a+b+c=2 or 3; and one of a number of specific conditions is met. OLED devices, consumer products, and formulations including the compound are also provided.

Abstract: A compound including a first ligand LA of Formula I, is disclosed. In Formula I, ring B is a 5- or 6-membered ring; X1, X2, and X3 are each CRA or N; R is a 5- or 6-membered carbocyclic or heterocyclic ring, which can be further fused or substituted; and (1) when ring B is an unfused 6-membered ring, X1 and X2 are N, and X3 is C; and (2) when ring B is a fused 6-membered ring, ring B has the structure of Formula II, In this structure, the wavy line indicates the point of connection to ring A; Q1 to Q6 are each C or N; and, when proviso (2) applies, (I) at least one of X1, X2, and X3 is N; or (II) R is two or more fused or unfused 5- or 6-membered carbocyclic or heterocyclic rings, or (III) at least ring A or R is substituted with a partially or fully deuterated alkyl or partially or fully deuterated cycloalkyl group.